Codexis (CDXS) stock jumps premarket after Q4 2025 earnings beat on Merck (MRK) deal and strong 2026 outlook. Read more here.

What makes NCT so exciting is that it focuses on the underlying problem: how the body converts fuel into energy.” — Damien Perriman, Chief Commercial Officer of eXoZymes LOS ANGELES, CA, UNITED STATES ...

Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.

We have harnessed rational strain engineering to pave the way for cost-effective manufacturing that can meet growing global ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient’s cells. However, most genetic disorders are caused by dozens or even thousands of ...

Researchers have uncovered a molecular trick used by hornwort plants that could help future crops capture carbon dioxide more efficiently. A unique protein feature called RbcS-STAR causes the key ...

Microbial bioelectronic sensors use living bacteria that can create an electrical signal in response to the presence of a ...

A bone-like composite developed at EPFL uses naturally occurring enzymes to accelerate mineralization through an ...

TOKYO, March 9, 2026 /PRNewswire/ -- bitBiome, Inc., a pioneer in the discovery, design, and engineering of novel bio-manufactured products, today announced a joint development and collaboration ...

Scientists have found a way to boost the efficiency of rubisco — the enzyme that powers life on Earth — and hope to transfer it to crops.

A new review outlines design principles and applications of synthetic membraneless organelles built through liquid-liquid phase separation for use in biotechnology.